Director/PDMR Shareholding

3 Jan 2007 16:40

Akers Biosciences, Inc.03 January 2007 AKERS BIOSCIENCES, INC. ISSUE OF EQUITY Akers Biosciences, Inc. today announces that on 28 December 2006 it approved theissue of 42,000 shares of common stock, no par value ("Common Shares") to DavidWilbraham, non-executive chairman, which represents 0.07% of the total sharecapital. The shares will be issued in lieu of unpaid directors' fees andexpenses in the amount of £18,690. The price per share for this transaction was44.5 pence. Following this announcement, Mr. Wilbraham is the beneficial owner of 370,000Common Shares representing 0.61% of the issued capital. Application has been made to the London Stock Exchange for the 42,000 CommonShares to be admitted to trading, such admission expected to take place on 5January 2007. Contact: Paul B. Freedman - 00 1 856 848 2116 This information is provided by RNS The company news service from the London Stock Exchange